JULIE TAYLOR: Open Payments
NPI 1063441525 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$25,424 in 71 payments from 15 companies in 2025. Trend: 2023 $757 · 2024 $36,732 · 2025 $25,424
Speaker / faculty: $24,530Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 24 | $24,530 |
| Novo Nordisk Inc | 10 | $210 |
| AstraZeneca Pharmaceuticals LP | 9 | $146 |
| Lilly USA, LLC | 5 | $97 |
| Astellas Pharma US Inc | 5 | $95 |
| ABBVIE INC. | 4 | $86 |
| SANOFI-AVENTIS U.S. LLC | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Abbott Laboratories | 1 | $25 |
Products named: OMNIPOD, Wegovy, AIRSUPRA, Veozah, VRAYLAR, MOUNJARO, TZIELD, JARDIANCE.
Industry payments across TX — which companies pay providers there.
